Amneal Pharmaceuticals (NYSE:AMRX) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, ValuEngine re
Amneal Pharmaceuticals Inc (NYSE:AMRX) was the target of a large drop in short interest during the month of February. As of February 14th, there was short interest totalling 3,940,000 shares, a drop o
California Public Employees Retirement System grew its stake in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 66.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The fir
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE